title: Cancer therapy. Less blood means more sanguinity.
abstract: Angiostatin, a recently discovered anti-angiogenic factor, offers the hope of long-term control of metastatic cancers following surgery.
authors.affiliation: Laboratory of Cancer Gene Therapy, Rayne Institute, St. Thomas' Hospital, London, UK.
authors.forename: R
authors.initials: R
authors.lastname: Vile
mesh_terms: D043168:Angiostatins; D000818:Animals; D006801:Humans; D009362:Neoplasm Metastasis / Q000503:physiopathology / Q000517:prevention & control*; D009389:Neovascularization, Pathologic / Q000517:prevention & control*; D010446:Peptide Fragments / Q000627:therapeutic use*; D010958:Plasminogen / Q000627:therapeutic use*
chemical_list: D010446:Peptide Fragments; D043168:Angiostatins; D010958:Plasminogen